Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 32

1.

Optimization of endochin-like quinolones for antimalarial activity.

Winter R, Kelly JX, Smilkstein MJ, Hinrichs D, Koop DR, Riscoe MK.

Exp Parasitol. 2011 Feb;127(2):545-51. doi: 10.1016/j.exppara.2010.10.016. Epub 2010 Oct 30.

PMID:
21040724
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Does atovaquone prolong the disease-free interval of toxoplasmic retinochoroiditis?

Winterhalter S, Severing K, Stammen J, Maier AK, Godehardt E, Joussen AM.

Graefes Arch Clin Exp Ophthalmol. 2010 Aug;248(8):1187-92. doi: 10.1007/s00417-010-1379-9. Epub 2010 May 2.

PMID:
20437247
[PubMed - indexed for MEDLINE]
3.

Toxoplasmosis in allo-SCT patients: risk factors and outcomes at a transplantation center with a low incidence.

Mulanovich VE, Ahmed SI, Öztürk T, Khokhar FA, Kontoyiannis DP, de Lima M.

Bone Marrow Transplant. 2011 Feb;46(2):273-7. doi: 10.1038/bmt.2010.102. Epub 2010 May 3.

PMID:
20436521
[PubMed - indexed for MEDLINE]
4.

Ocular toxoplasmosis in the developing world.

Arevalo JF, Belfort R Jr, Muccioli C, Espinoza JV.

Int Ophthalmol Clin. 2010 Spring;50(2):57-69. doi: 10.1097/IIO.0b013e3181d26bf4. Review. No abstract available.

PMID:
20375862
[PubMed - indexed for MEDLINE]
5.

In vitro and in vivo activities of 1-hydroxy-2-alkyl-4(1H)quinolone derivatives against Toxoplasma gondii.

Bajohr LL, Ma L, Platte C, Liesenfeld O, Tietze LF, Gross U, Bohne W.

Antimicrob Agents Chemother. 2010 Jan;54(1):517-21. doi: 10.1128/AAC.01001-09. Epub 2009 Nov 2.

PMID:
19884369
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The history of Toxoplasma gondii--the first 100 years.

Dubey JP.

J Eukaryot Microbiol. 2008 Nov-Dec;55(6):467-75. doi: 10.1111/j.1550-7408.2008.00345.x. Review.

PMID:
19120791
[PubMed - indexed for MEDLINE]
7.

Mutations in cytochrome b that affect kinetics of the electron transfer reactions at center N in the yeast cytochrome bc1 complex.

Rotsaert FA, Covian R, Trumpower BL.

Biochim Biophys Acta. 2008 Mar;1777(3):239-49. doi: 10.1016/j.bbabio.2007.08.005. Epub 2007 Sep 6.

PMID:
18328328
[PubMed - indexed for MEDLINE]
Free Article
8.

In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.

Meneceur P, Bouldouyre MA, Aubert D, Villena I, Menotti J, Sauvage V, Garin JF, Derouin F.

Antimicrob Agents Chemother. 2008 Apr;52(4):1269-77. doi: 10.1128/AAC.01203-07. Epub 2008 Jan 22.

PMID:
18212105
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Antimalarial quinolones: synthesis, potency, and mechanistic studies.

Winter RW, Kelly JX, Smilkstein MJ, Dodean R, Hinrichs D, Riscoe MK.

Exp Parasitol. 2008 Apr;118(4):487-97. Epub 2007 Nov 7.

PMID:
18082162
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Toxoplasma gondii infection in the United States, 1999 2004, decline from the prior decade.

Jones JL, Kruszon-Moran D, Sanders-Lewis K, Wilson M.

Am J Trop Med Hyg. 2007 Sep;77(3):405-10.

PMID:
17827351
[PubMed - indexed for MEDLINE]
Free Article
11.

Modeling the molecular basis of atovaquone resistance in parasites and pathogenic fungi.

Kessl JJ, Meshnick SR, Trumpower BL.

Trends Parasitol. 2007 Oct;23(10):494-501. Epub 2007 Sep 7. Review.

PMID:
17826334
[PubMed - indexed for MEDLINE]
12.

Molecular basis of Toxoplasma gondii atovaquone resistance modeled in Saccharomyces cerevisiae.

Kessl JJ, Ha KH, Merritt AK, Meshnick SR, Trumpower BL.

Mol Biochem Parasitol. 2006 Apr;146(2):255-8. Epub 2005 Dec 27. No abstract available.

PMID:
16412524
[PubMed - indexed for MEDLINE]
13.

The effect of endochin on experimental toxoplasmosis.

GINGRICH WD, DARROW EM.

Am J Trop Med Hyg. 1951 Jan;31(1):12-7. No abstract available.

PMID:
14799708
[PubMed - indexed for MEDLINE]
14.

Recapitulation in Saccharomyces cerevisiae of cytochrome b mutations conferring resistance to atovaquone in Pneumocystis jiroveci.

Hill P, Kessl J, Fisher N, Meshnick S, Trumpower BL, Meunier B.

Antimicrob Agents Chemother. 2003 Sep;47(9):2725-31.

PMID:
12936966
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii.

Jones-Brando L, Torrey EF, Yolken R.

Schizophr Res. 2003 Aug 1;62(3):237-44.

PMID:
12837520
[PubMed - indexed for MEDLINE]
16.

Efficacy of atovaquone combined with clindamycin against murine infection with a cystogenic (Me49) strain of Toxoplasma gondii.

Djurković-Djaković O, Milenković V, Nikolić A, Bobić B, Grujić J.

J Antimicrob Chemother. 2002 Dec;50(6):981-7.

PMID:
12461021
[PubMed - indexed for MEDLINE]
Free Article
17.

Randomized phase II trial of atovaquone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039.

Chirgwin K, Hafner R, Leport C, Remington J, Andersen J, Bosler EM, Roque C, Rajicic N, McAuliffe V, Morlat P, Jayaweera DT, Vilde JL, Luft BJ.

Clin Infect Dis. 2002 May 1;34(9):1243-50.

PMID:
11941551
[PubMed - indexed for MEDLINE]
Free Article
18.

Characterization of cytochrome b from Toxoplasma gondii and Q(o) domain mutations as a mechanism of atovaquone-resistance.

McFadden DC, Tomavo S, Berry EA, Boothroyd JC.

Mol Biochem Parasitol. 2000 Apr 30;108(1):1-12.

PMID:
10802314
[PubMed - indexed for MEDLINE]
20.

Sequence polymorphisms in the Pneumocystis carinii cytochrome b gene and their association with atovaquone prophylaxis failure.

Walker DJ, Wakefield AE, Dohn MN, Miller RF, Baughman RP, Hossler PA, Bartlett MS, Smith JW, Kazanjian P, Meshnick SR.

J Infect Dis. 1998 Dec;178(6):1767-75.

PMID:
9815231
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk